Key Benefits
• Inhibits Candida albicans biofilm formation in the vagina• Suppresses vaginal pathogens through oral administration• Restores and maintains healthy vaginal microbiota balance
Key Data
• Orally administered strain reaches the vaginal tract via specific pathways – systemic translocation mechanism• Directly inhibits biofilm formation of Candida albicans, a primary cause of recurrent vulvovaginal candidiasis• Addresses vaginal infections by targeting pathogenic biofilms
Commercial Use
Featured in women's probiotics (private care & beauty) blends alongside Lactobacillus reuteri HR7, Lactobacillus casei CN1566, and Lactobacillus rhamnosus LR663
Why Choose QJSWX19TM1?
Specifically developed for vaginal health – a fast-growing segment in women's wellness
Works through a unique oral delivery pathway to reach the vaginal tract – more consumer-friendly than topical applications
Specifically targets biofilm formation – a key virulence factor of C. albicans that makes infections recurrent and hard to treat
Ideal for women's health supplements targeting recurrent vaginal infections, microbiota imbalance, and daily feminine wellness
